Business Wire
BusinessAmgen vs. Eli Lilly: GLP-1 obesity-drug hype is reshaping how investors price two biotech giantsThe Apex TimesBusinessNetflix stock climbs after profitability beat, even as investors weigh guidance riskThe Apex TimesBusinessBoeing set for next-week earnings, with analysts forecasting double-digit growth in key profit measureThe Apex TimesBusinessDisney stock edges higher after a market dip, closing up 1% in latest sessionThe Apex TimesBusinessBoeing shares slip more than the overall market as investors weigh company-specific concernsThe Apex TimesBusinessWhy Deere (DE) rose even as broader markets dipped on the dayThe Apex TimesBusinessBerkshire Hathaway B shares rise even as market pulls back, closing at $546.90The Apex TimesBusinessBroadcom shares fall more than the broader market in latest session, AVGO closes down 4.3%The Apex TimesBusinessCoca-Cola (KO) gains after market dips as shares settle at $95.34The Apex TimesBusinessCommentary Links Spotify’s Share Move to Its “Simple Formula,” as Investors Focus on the Streaming MixThe Apex TimesBusinessPfizer’s Revenue Dip Versus Bristol Myers Squibb’s Steady Climb Highlights a Consistency-Scale TradeoffThe Apex TimesBusinessSalesforce plans to buy Braze in a deal valued around $5.66 billion, aiming to deepen real-time AI marketingThe Apex TimesBusinessAmgen vs. Eli Lilly: GLP-1 obesity-drug hype is reshaping how investors price two biotech giantsThe Apex TimesBusinessNetflix stock climbs after profitability beat, even as investors weigh guidance riskThe Apex TimesBusinessBoeing set for next-week earnings, with analysts forecasting double-digit growth in key profit measureThe Apex TimesBusinessDisney stock edges higher after a market dip, closing up 1% in latest sessionThe Apex TimesBusinessBoeing shares slip more than the overall market as investors weigh company-specific concernsThe Apex TimesBusinessWhy Deere (DE) rose even as broader markets dipped on the dayThe Apex TimesBusinessBerkshire Hathaway B shares rise even as market pulls back, closing at $546.90The Apex TimesBusinessBroadcom shares fall more than the broader market in latest session, AVGO closes down 4.3%The Apex TimesBusinessCoca-Cola (KO) gains after market dips as shares settle at $95.34The Apex TimesBusinessCommentary Links Spotify’s Share Move to Its “Simple Formula,” as Investors Focus on the Streaming MixThe Apex TimesBusinessPfizer’s Revenue Dip Versus Bristol Myers Squibb’s Steady Climb Highlights a Consistency-Scale TradeoffThe Apex TimesBusinessSalesforce plans to buy Braze in a deal valued around $5.66 billion, aiming to deepen real-time AI marketingThe Apex TimesBusinessAmgen vs. Eli Lilly: GLP-1 obesity-drug hype is reshaping how investors price two biotech giantsThe Apex TimesBusinessNetflix stock climbs after profitability beat, even as investors weigh guidance riskThe Apex TimesBusinessBoeing set for next-week earnings, with analysts forecasting double-digit growth in key profit measureThe Apex TimesBusinessDisney stock edges higher after a market dip, closing up 1% in latest sessionThe Apex TimesBusinessBoeing shares slip more than the overall market as investors weigh company-specific concernsThe Apex TimesBusinessWhy Deere (DE) rose even as broader markets dipped on the dayThe Apex TimesBusinessBerkshire Hathaway B shares rise even as market pulls back, closing at $546.90The Apex TimesBusinessBroadcom shares fall more than the broader market in latest session, AVGO closes down 4.3%The Apex TimesBusinessCoca-Cola (KO) gains after market dips as shares settle at $95.34The Apex TimesBusinessCommentary Links Spotify’s Share Move to Its “Simple Formula,” as Investors Focus on the Streaming MixThe Apex TimesBusinessPfizer’s Revenue Dip Versus Bristol Myers Squibb’s Steady Climb Highlights a Consistency-Scale TradeoffThe Apex TimesBusinessSalesforce plans to buy Braze in a deal valued around $5.66 billion, aiming to deepen real-time AI marketingThe Apex TimesBusinessAmgen vs. Eli Lilly: GLP-1 obesity-drug hype is reshaping how investors price two biotech giantsThe Apex TimesBusinessNetflix stock climbs after profitability beat, even as investors weigh guidance riskThe Apex TimesBusinessBoeing set for next-week earnings, with analysts forecasting double-digit growth in key profit measureThe Apex TimesBusinessDisney stock edges higher after a market dip, closing up 1% in latest sessionThe Apex TimesBusinessBoeing shares slip more than the overall market as investors weigh company-specific concernsThe Apex TimesBusinessWhy Deere (DE) rose even as broader markets dipped on the dayThe Apex TimesBusinessBerkshire Hathaway B shares rise even as market pulls back, closing at $546.90The Apex TimesBusinessBroadcom shares fall more than the broader market in latest session, AVGO closes down 4.3%The Apex TimesBusinessCoca-Cola (KO) gains after market dips as shares settle at $95.34The Apex TimesBusinessCommentary Links Spotify’s Share Move to Its “Simple Formula,” as Investors Focus on the Streaming MixThe Apex TimesBusinessPfizer’s Revenue Dip Versus Bristol Myers Squibb’s Steady Climb Highlights a Consistency-Scale TradeoffThe Apex TimesBusinessSalesforce plans to buy Braze in a deal valued around $5.66 billion, aiming to deepen real-time AI marketingThe Apex Times
Back to front
Lockheed Martin shares jump after raised outlook, third-quarter EPS beat, and large F-35 order
The Apex Times

THE APEX TIMES

Business/The Apex Times/Oct 22, 5:44 PM EDT

Lockheed Martin shares jump after raised outlook, third-quarter EPS beat, and large F-35 order

Lockheed Martin (LMT) climbed about 7% following its third-quarter results, a reported earnings-per-share beat, and commentary tied to a major F-35 buy involving 850 jets.

Lockheed Martin’s stock surged by roughly 7% after the company reported third-quarter results that topped Wall Street expectations and, according to market coverage, raised its outlook. The move also came alongside renewed attention to a sizable F-35 procurement push described in the same coverage as involving 850 aircraft, reinforcing investor focus on sustained defense production and earnings momentum.

The market reaction tracked the company’s reported third-quarter earnings per share of $7.97, which the coverage said beat the consensus estimate of $7.00. While the coverage does not provide additional breakdowns of revenue, margins, or cash flow in the excerpt available here, the EPS figure itself was enough to drive an immediate repricing of the shares.

The same report attributed the advance to a combination of the EPS beat and an increase to the company’s outlook. In corporate earnings terms, an outlook raise typically indicates management expects stronger performance in the coming quarters than it previously forecast, a lever that can matter as much as a single quarter’s results in defense and industrials where program schedules and production rates weigh on estimates.

The report also framed Lockheed Martin’s momentum around the F-35 program, specifically pointing to a deal described as covering 850 jets. The F-35 is the United States-led joint strike fighter program, and large multi-aircraft buys are closely watched because they can translate into multi-year production workloads for prime contractors and their supply chains.

Defense contracting can be a steady business, but it is also exposed to political and budget timing. Investors typically monitor whether procurement plans change from one budget cycle to the next, whether delivery schedules hold, and whether production rates ramp or slow. In that context, coverage that emphasizes both an earnings beat and a large near-term aircraft procurement footprint tends to be read as a announcement of continuity in demand.

Still, not all details are visible in the market summary available for this story. The excerpt here does not specify how Lockheed Martin defined its raised outlook, the timeframe of the forecast update, or the exact structure and timing of the reported 850-jet F-35 agreement. It also does not include guidance ranges, segment-level performance, or program-level deliveries that would allow a full read-through of what portion of the improved outlook is already under contract versus subject to future awards.

Looking ahead, traders and analysts will likely watch the next set of disclosures for the missing specifics, including the company’s updated financial targets and any more detailed language around F-35 procurement timing, delivery schedules, and program economics. For the broader sector, the key question remains whether the combination of raised forecasts and large aircraft buys continues to translate into stable earnings and cash generation across the remainder of the fiscal year.

Why It Matters

  • In defense manufacturing, raised outlook language can materially shift expectations for subsequent quarters, especially when paired with a large procurement reference.
  • Large F-35 buy numbers are closely monitored because they can indicate multi-year production workloads and revenue visibility for prime contractors.
  • A quick post-earnings stock move suggests investors viewed the results and outlook update as more favorable than anticipated, even without the full detail in the available excerpt.

Sources

Key Facts

  • Lockheed Martin shares rose about 7% following the release of third-quarter results, according to market coverage.
  • Lockheed Martin reported third-quarter earnings per share of $7.97, which the coverage said beat a $7.00 consensus estimate.
  • The market coverage said the company raised its outlook after the third-quarter results.
  • The coverage linked the stock move to renewed attention on an F-35 deal described as involving 850 jets.

Defense Related

Oct 22, 3:24 PM EDT
The Apex Times

Booz Allen’s Steve Escaravage to appear in AUSA interview with J.D. Durkin

A newly posted Yahoo Finance video preview says Steve Escaravage from Booz Allen Hamilton is scheduled to join J.D. Durkin at AUSA 2026, indicating the firm’s continued push for visibility in U.S. defense circles. The posting does not specify what topics will be covered.

Booz Allen’s Steve Escaravage to appear in AUSA interview with J.D. Durkin
The Apex Times